Ms. TAI has 28 years’ experience as an IP practitioner, and worked with one of China's largest IP firms for long time as the executive member before joining KWM.
Ms. TAI is one of the most influential figures in IP law in the pharmaceutical and healthcare sectors, and has represented many influential cases including the Viagra® (Sildenafil) and Lipitor® (Atrovastatin) for Pfizer, Brillinta® (Ticagrelor) for AstraZeneca, Xarelto® (Rivaroxaban) for Bayer, Actemra® (Tocilizumab) and Xofluza® (baloxavir marboxil) for Roche/Chugai, Victoza® (Liraglutide) and Wegovy® (semaglutide) for Novo Nordisk, Entresto® (Valsartan Sacubitril) and Revolade® (Eltrombopag) for Novartis, in the patent invalidation and infringement litigations.
Ms. TAI is recognized in the international intellectual property community as one of the World’s Leading Patent Practitioners and Leading Lawyer by MIP and IAM for many consecutive years. Ms. TAI was named “Eminent Practitioner” in the category of intellectual property non-litigation by Chambers Asia Pacific Guide consecutively from 2016 to 2020, and was named “Leading Lawyer” in the category of intellectual property non-litigation from 2021 to 2024. Ms. TAI was selected as The 250 Top Women in IP by MIP from 2021 to 2022 and was selected as IP STARS by MIP from 2019 to 2023. She was also selected as one of 2021 ALB China Top 15 IP Lawyers. Ms. TAI was selected as one of the “Leading Lawyers” by Asialaw Profiles in 2020. Ms. TAI was one of the recommended lawyers in the field of IP recognized by The Legal 500 in 2020 and 2022 to 2024, and was one of the recommended lawyers in the field of Healthcare and Life Sciences recognized by The Legal 500 in 2023. Ms. TAI was included in IAM Patent 1000 in 2019 and 2022 to 2023. She was also selected as one of the first National IP Leading Experts and awarded by the then SIPO as one of the “First Leading Patent Attorneys in China”. She is the perennial counselor-at-law of INTERPAT and RDPAC (R&D pharmaceutical association committee).
Year Joined Firm: 2019
Education/Alumni: Ms. Tai graduated from Peking University with a bachelor's degree in applied chemistry and a master's degree in polymer radiation chemistry. In 2003, she obtained L.L.M from the University of London.
